US chief medical adviser, Dr. Anthony Fauci, speaks in an interview
This will keep market participants pleased in brushing aside the recent AstraZeneca worries that have been cropping up in Europe. If anything, this also makes clearer the vaccine divergence between the US and Europe – which .